Huntington’s Disease Clinical Trials Corner: March 2024
Journal of Huntington's Disease · 29.03.2024 · 13 (1) · 1-14
DOI: 10.3233/jhd-240017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Huntington's Disease, erschienen am 29.03.2024. Verfasst von Carlos Estevez-Fraga und 2 weiteren Autor:innen. Beteiligte Einrichtung: Huntington's Disease Centre, UCL Queen Square Institute of Neurology, London, UK. Hauptthemen laut MEDLINE: Huntington Disease. Die Arbeit wurde bisher 44-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
In this edition of the Huntington’s Disease Clinical Trials Update, we expand on the ongoing program from VICO Therapeutics and on the recently terminated VIBRANT-HD clinical trials. We also discuss updates from uniQure’s AMT-130 program and PTC therapeutics’ trial of PTC518 and list all currently registered and ongoing clinical trials in Huntington’s disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Huntington's Disease Centre, UCL Queen Square Institute of Neurology, London, UK.
Zitieren
APA
Estevez-Fraga, C., Tabrizi, S. J., & Wild, E. J. (2024). Huntington’s Disease Clinical Trials Corner: March 2024. Journal of Huntington's Disease, 13(1), 1-14. https://doi.org/10.3233/jhd-240017
Vancouver
Estevez-Fraga C, Tabrizi SJ, Wild EJ. Huntington’s Disease Clinical Trials Corner: March 2024. Journal of Huntington's Disease. 2024;13(1):1-14. doi:10.3233/jhd-240017
BibTeX
@article{EstevezFraga2024,
author = {Estevez-Fraga, Carlos and Tabrizi, Sarah J and Wild, Edward J},
title = {Huntington’s Disease Clinical Trials Corner: March 2024},
journal = {Journal of Huntington's Disease},
year = {2024},
volume = {13},
number = {1},
pages = {1--14},
doi = {10.3233/jhd-240017}
}
EUVIMED